𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas

✍ Scribed by Quynh-Thu Le; Al Taira; Sherie Budenz; Mary Jo Dorie; Don R. Goffinet; Willard E. Fee; Richard Goode; Daniel Bloch; Albert Koong; J. Martin Brown; Harlan A. Pinto


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
255 KB
Volume
106
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A phase III randomized trial comparing c
✍ David J. Adelstein; Jerrold P. Saxton; Pierre Lavertu; Laurie Tuason; Benjamin G πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 2 views

Background. A phase III randomized comparison of radiotherapy alone versus combination chemotherapy and concurrent continuous-course radiotherapy was performed at the Cleveland Clinic Foundation. Methods. Between March 1990 and June 1995, 100 patients with resectable stage III and IV squamous cell

Mature results of a Phase III randomized
✍ David J. Adelstein; Pierre Lavertu; Jerrold P. Saxton; Michelle Secic; Benjamin πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 3 views

The current study presents mature results from a Phase III randomized trial comparing radiation therapy and concurrent chemoradiotherapy in patients with resectable American Joint Committee on Cancer Stage III and IV disease.

A phase II trial of cisplatin and vinore
✍ Enrique Espinosa; Pilar Zamora; Alfredo MillΓ‘; Serafin Morales; Raquel Molina; M πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

## Abstract ## Objective. We assessed the response rate and the toxicity of cisplatin plus vinorelbine in patients with this condition. ## Patients and Method. Forty‐two patients were included. Therapy consisted of cisplatin, 100 mg/m^2^ on day 1, and vinorelbine, 25 mg/m^2^ on days 1 and 8, giv

Phase II trial of dose-dense paclitaxel,
✍ Ricardo Hitt; Antonio Jimeno; Jose MarΓ­a MillΓ‘n; Daniel Castellano; HernΓ‘n CortΓ© πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 4 views

## Abstract ## BACKGROUND The current study evaluated the feasibility and clinical activity of a combination of paclitaxel, cisplatin, 5‐fluorouracil (5‐FU), and leucovorin administered on a biweekly schedule to patients with recurrent or unresectable squamous cell carcinoma of the head and neck (

A phase II trial of cisplatin, methotrex
✍ Francesco Caponigro; Pasquale Comella; Paolo Marcolin; Francesco Russo Spena; Ma πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 2 views

## Background: Induction chemotherapy in locoregionally advanced squamous cell carcinoma of the head and neck (scchn) might improve survival with respect to radiation therapy alone. furthermore, chemotherapy represents the only therapeutic option in metastatic head and neck carcinoma. ## Methods: